Antisense modulation of integrin-linked kinase expression

Details for Australian Patent Application No. 2004201138 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Not Given

Agent FB Rice

Pub. Number AU-A-2004201138

Parent 768799

Filing date 18 March 2004

Wipo publication date 22 April 2004

International Classifications

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 021/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

1 April 2004 Complete Application Filed

22 April 2004 Application Open to Public Inspection

  Published as AU-A-2004201138

8 September 2005 Amendment Made

  The nature of the amendment is: Add co-inventors Bennett, Frank C. Cowsert, Lex M.

31 May 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004201139-Ligands for induction of antigen specific apoptosis in T cells

2004201137-Lower Limb Function Training Device